Inorganic Nitrate Supplementation on Cerebrovascular Aging and Arterial Stiffness Study (INCA)
Effects of Inorganic Nitrate Supplementation on Cerebrovascular Aging and Arterial Stiffness Study
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Early Phase 1
Contacts and Locations
Study Contact
Study Contact
- Name: Gary L Pierce, PhD
- Phone Number: (319)335-9487
- Email: gary-pierce@uiowa.edu
Study Contact Backup
- Name: Amy Stroud, RN
- Phone Number: 3193562710 (319)356-2710
- Email: amy-stroud@uiowa.edu
Study Locations
-
-
Iowa
-
Iowa City, Iowa, United States, 52242
- University of Iowa
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age 50-79 years
- Cognitively healthy, having mild cognitive impairment
- Able to undergo cardiovascular testing procedures including fasting overnight and holding selected morning medication doses.
- Ability to understand and willingness to sign a written informed consent document.
- Ability to lie comfortably for up to 90 minutes
- Women only: Post-menopausal
Exclusion Criteria:
- Current or history of cardiovascular disease disease (heart attack, stroke, heart failure, cardiomyopathy or peripheral artery disease, heart angioplasty/stent or bypass surgery, valve replacement, carotid endarterectomy, heart transplant.
- Medical history of stroke or other neurological disorder or systemic illness that could potentially affect cognition or brain function (outside of a diagnosis of Mild Cognitive impairment, Alzheimer's Disease) or could affect their safety or comfort while undergoing the imaging or cardiovascular studies.
- Subjects with evidence of cardiovascular disease at baseline or during the exercise test (evidence of myocardial infarction, abnormal cardiac arrhythmia, myocardial ischemia, conduction delays, >1mm S-T segment depression or elevation; >3 beat ventricular tachycardia; atrial fibrillation) will be excluded from the study.
- Wilson's disease, hemochromatosis
- Individuals taking clonidine or other short-acting beta blocker
- Resting blood pressure > 200/ 110 mmHg or systolic <90 mmHg
- Medical history of chronic major psychiatric or current diagnosis of major psychiatric disease (other than dementia).
- Systemic illness or neurological disorder potentially affecting cognition or cerebral blood flow other than mild cognitive impairment
- Unable to provide informed consent due to cognitive impairment
- Currently taking medications that may affect cerebral blood flow (e.g. papaverine, indomethacin, acetazolamide, etc) or efficacy of beetroot juice (proton pump inhibitors)
- Current clinically abnormal thyroid function not adequately regulated by thyroid hormone supplementation or medication.
- Allergic to beets
- Current tobacco user or history of tobacco use within the past 3 months (cigarettes, cigars, chewing tobacco, hookah, electronic cigarettes) or living with someone who smokes/has smoked in the past 3 months.
- Current diagnosis of insulin-dependent diabetes (Type I or insulin dependent Type II)
- Current diagnosis of chronic obstructive lung disease, cystic fibrosis, emphysema, chronic bronchitis
- History of renal failure, dialysis or kidney transplant
- Current diagnosis or history of liver disease or HIV/AIDS, or cancer (other than non-melanoma skin cancers).
- Current diagnosis or history of rheumatoid arthritis, systemic lupus erythematosus, Wegener's granulomatosis
- Vulnerable populations (prisoners, etc) will not be eligible.
- Unwillingness to wash out from a vitamin or dietary supplement regime prior to enrollment and maintain throughout the duration of the study.
- Inability to comply with experimental instructions.
- Uncontrolled intercurrent illness that would limit compliance with study requirements per investigator.
- Inability to fast or hold morning medications doses until after testing is complete.
- Hormone replacement use within the past 6 months
- Currently enrolled in another study using an study medication, supplement, device or intervention.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Placebo Comparator: Placebo Beetroot juice
10 grams of nitrate-depleted beetroot concentrate balanced for anti-oxidant content diluted in 120-180 milliliters of water.
|
Placebo
|
|
Active Comparator: Beetroot juice
10-grams of nitrate-containing beetroot concentrate diluted in 120-180 milliliters of water.
|
Experimental
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Carotid Artery Compliance in mm/mmHg x 10-1
Time Frame: Baseline and 2 hours following nitrate-depleted placebo beetroot juice or nitrate-containing beetroot juice
|
Common carotid artery compliance measured by ultrasonography and applanation tonometry.
Carotid compliance is the change in carotid diameter per change in carotid pulse pressure.
|
Baseline and 2 hours following nitrate-depleted placebo beetroot juice or nitrate-containing beetroot juice
|
|
Change in Carotid Augmentation Index
Time Frame: Baseline and 2 hours following nitrate-depleted beetroot juice or nitrate-containing beetroot juice
|
Carotid Augmentation Index is calculated as the augmentation pressure divided by the pulse pressure, and expressed as a percentage.
Higher augmentation index percentage is a worse outcome than lower percentage.
|
Baseline and 2 hours following nitrate-depleted beetroot juice or nitrate-containing beetroot juice
|
|
Change in Carotid Pulse Pressure in mmHg
Time Frame: Baseline and 2 hours following nitrate-depleted beetroot juice or nitrate-containing beetroot juice
|
Carotid pulse pressure measured by carotid tonometry calibrated to brachial mean and diastolic pressure.
Carotid pulse pressure is the difference between carotid systolic blood pressure and diastolic blood pressure.
|
Baseline and 2 hours following nitrate-depleted beetroot juice or nitrate-containing beetroot juice
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Internal carotid artery endothelium-dependent dilation
Time Frame: 2-hours
|
Endothelium-dependent dilation of the internal carotid artery in response to hypercapnia will be measured using ultrasonography.
|
2-hours
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Gary Pierce, PhD, University of Iowa
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 201805720
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.